|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
48,973,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Co.'s D-Domain powered autologous and allogeneic Chimeric Antigen Receptor T cells (CAR-Ts), including classical single infusion CAR-Ts product candidate, CART-ddBCMA, is for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM), defined as patients with either minimal response or disease progression within 60 days of last treatment. Co. is also developing its ARC-SparX programs, ACLX-001 in r/r MM and ACLX-002 and ACLX-003 in r/r acute myeloid leukemia and myelodysplastic syndrome.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
312,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$5,000,000 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
665,735 |
1,335,183 |
3,353,154 |
3,456,214 |
Total Sell Value |
$46,017,101 |
$79,309,104 |
$168,911,661 |
$172,412,706 |
Total People Sold |
5 |
5 |
6 |
10 |
Total Sell Transactions |
14 |
19 |
30 |
45 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Elghandour Rami |
See Remarks |
|
2023-02-09 |
4 |
S |
$30.77 |
$967,423 |
D/D |
(31,442) |
38,769 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-02-09 |
4 |
S |
$30.77 |
$214,333 |
D/D |
(6,966) |
15,589 |
|
- |
|
Elghandour Rami |
See Remarks |
|
2023-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,211 |
70,211 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,555 |
22,555 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-02-03 |
4 |
AS |
$35.11 |
$44,068 |
D/D |
(1,255) |
0 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-02-03 |
4 |
OE |
$6.28 |
$15,337 |
D/D |
1,255 |
1,255 |
|
- |
|
Gilson Michelle |
Chief Financial Officer |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,339 |
24,824 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-01-03 |
4 |
AS |
$31.11 |
$77,775 |
D/D |
(2,500) |
0 |
|
- |
|
Heery Christopher |
Chief Medical Officer |
|
2023-01-03 |
4 |
OE |
$15.00 |
$37,500 |
D/D |
2,500 |
2,500 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-12-23 |
4 |
S |
$31.67 |
$12,353 |
I/I |
(390) |
0 |
|
- |
|
Baskett Forest |
10% Owner |
|
2022-12-22 |
4 |
S |
$31.45 |
$51,207 |
I/I |
(1,628) |
0 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-12-21 |
4 |
S |
$30.74 |
$5,502 |
I/I |
(179) |
0 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-12-21 |
4 |
S |
$30.74 |
$5,502 |
I/I |
(179) |
0 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2022-12-21 |
4 |
S |
$30.74 |
$5,502 |
I/I |
(179) |
0 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
30,179 |
179 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
283 |
283 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
31,801 |
179 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
Sonsini Peter W. |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
30,821 |
12 |
|
- |
|
Sonsini Peter W. |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
30,179 |
179 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
New Enterprise Associates 15, L.p. |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
4,745,262 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
0 |
|
- |
|
84 Records found
|
|
Page 3 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|